Cystic fibrosis patients running a marathon race

Area of Science:

• Exercise physiology
• Pulmonary medicine
• Sports science

Background:

• Cystic fibrosis (CF) is a genetic disorder affecting multiple organs, primarily the lungs.
• Individuals with CF often experience respiratory challenges impacting physical performance.
• Endurance running requires significant cardiorespiratory and metabolic adaptations.

Purpose of the Study:

• To document the participation and performance of marathon runners with cystic fibrosis.
• To present the characteristics of these athletes and their running experiences.
• To highlight the feasibility of completing endurance events in individuals with CF.

Main Methods:

• Case study presentation of three male marathon runners with diagnosed cystic fibrosis.
• Data collection included race times, environmental conditions, and participant characteristics.
• Descriptive analysis of the runners' performances during the 1984 New York Marathon.

Main Results:

• All three male runners with CF successfully completed the New York Marathon in 1984.
• Finishing times ranged from 4:32:15 to 6:10:33 under warm weather conditions.
• Detailed characteristics of the athletes and their companions were recorded.

Conclusions:

• Marathon running is achievable for individuals with cystic fibrosis.
• Successful completion suggests that CF may not be an absolute contraindication to extreme endurance exercise.
• Further research into CF management for athletes is warranted.